Tevard Biosciences and Vertex Partner to Create Breakthrough tRNA-Based Treatments for Duchenne Muscular Dystrophy Read more
Reata Pharmaceuticals Announces FDA Approval of SKYCLARYS (Omaveloxolone), the First and Only Drug Indicated for Patients with Friedreich’s Ataxia Read more
Tempus Announces New Strategic Collaboration with Pfizer to Advance Oncology Therapeutic Development Read more
Rhythm Pharmaceuticals Announces Acquisition of Xinvento B.V. and Portfolio of Investigational Therapeutics Read more
Azenta Launches Cryo Store Pico, a Novel Automated Cryogenic Storage System Designed for Clinical and Laboratory Applications Read more
AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ) for the Treatment of Adults with Moderate to Severe Crohn’s Disease Read more
Ocugen, Inc. Announces Submission of Investigational New Drug Application with U.S. FDA to Initiate a Phase 1 Clinical Trial Evaluating OCU200 for the Treatment of Diabetic Macular Edema Read more
Lantern Pharma and TTC Oncology Establish AI Collaboration to Expand the Clinical Development of Drug Candidate TTC-352 Read more
Keymed and Lepu Biopharma have announced a global exclusive licensing agreement with AstraZeneca for CMG901 Read more